Biogenics Labs Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.06 Cr
- Revenue Growth 263.37%
- Profit Growth 108.61%
- Ebitda 126.98%
- Net Worth 81.79%
- Total Assets 81.39%
About Biogenics Labs
Biogenics Labs Private Limited (BLPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 May 2011 and has a history of 13 years and nine months. Its registered office is in Pune, Maharashtra, India.
The Corporate was formerly known as Diagnogenese Healthcare Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.06 Cr.
Chetan Rawal and Gajalakshmi Purushottam serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74900PN2011PTC139509
-
Company No.
139509
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 May 2011
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Biogenics Labs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gajalakshmi Purushottam
|
Director | 18-Jul-2019 | Current |
|
Chetan Rawal
|
Director | 11-May-2011 | Current |
Financial Performance of Biogenics Labs.
Biogenics Labs Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 263.37% increase. The company also saw a substantial improvement in profitability, with a 108.61% increase in profit. The company's net worth Soared by an impressive increase of 81.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biogenics Labs?
In 2019, Biogenics Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bharakt Diagnostics Private LimitedChetan Rawal and Gajalakshmi Purushottam are mutual person
Charges (Loans)
₹50.58 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 5.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Dec 2023 | Hdfc Bank Limited | ₹5.06 Cr | Open |
How Many Employees Work at Biogenics Labs?
Unlock and access historical data on people associated with Biogenics Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biogenics Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biogenics Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
